Targets is a peer-reviewed english-language open-access journal published by MDPI AG in Switzerland, operating under an open-access model since 2023. The journal covers Medicine (General).
Authors are required to pay an article processing charge to publish in Targets; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY license (see other journals using this license).
To date, Targets has published 85 articles. Articles are minted with DOIs through the prefix 10.3390. All submissions undergo plagiarism screening before peer review.
Keywords
biological interaction, molecular analysis, drug targeting, targeted therapy, diagnostic biomarkers
At a glance
- Publisher
- MDPI AG
- Country
- Switzerland
- Primary language
- English
- License
- CC BY
- Peer review
- Anonymous peer review
- OA since
- 2023
- Review time
- 6 weeks
- DOI prefix
10.3390- Plagiarism check
- Yes
ISSN
- electronic
- 2813-3137
Frequently asked questions
Is Targets peer-reviewed?
Yes — Targets operates a Anonymous peer review review process.
Does Targets charge an article processing charge (APC)?
Yes — refer to the journal's APC page for the current rate. A waiver policy is available for eligible authors.
What subjects does Targets publish?
Targets publishes research in Medicine (General).
What languages does Targets accept?
Targets accepts manuscripts in English.
What is the ISSN of Targets?
ISSN:
2813-3137 (electronic).How do I submit a manuscript to Targets?
Submit through the journal's official portal: visit submission page →
How long does peer review take at Targets?
Average time from submission to publication is approximately 6 weeks.